H. Keen

22.4k total citations · 5 hit papers
259 papers, 16.4k citations indexed

About

H. Keen is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, H. Keen has authored 259 papers receiving a total of 16.4k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Endocrinology, Diabetes and Metabolism, 43 papers in Physiology and 41 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in H. Keen's work include Diabetes Management and Research (64 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (58 papers) and Diabetes and associated disorders (31 papers). H. Keen is often cited by papers focused on Diabetes Management and Research (64 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (58 papers) and Diabetes and associated disorders (31 papers). H. Keen collaborates with scholars based in United Kingdom, United States and Canada. H. Keen's co-authors include R. J. Jarrett, John C. Pickup, J. H. Fuller, Giancarlo Viberti, G C Viberti, R. J. Jarrett, R.D. Hill, Peter McCartney, Gian Carlo Viberti and Martin Wiseman and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

H. Keen

253 papers receiving 14.9k citations

Hit Papers

MICROALBUMINURIA AS A PRE... 1978 2026 1994 2010 1982 2001 1983 1978 1982 400 800 1.2k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
H. Keen 9.1k 3.5k 3.1k 2.8k 2.3k 259 16.4k
James H. Warram 6.4k 0.7× 2.8k 0.8× 5.2k 1.7× 3.5k 1.2× 2.5k 1.1× 190 17.3k
K. Borch‐Johnsen 5.5k 0.6× 3.0k 0.9× 2.2k 0.7× 1.7k 0.6× 1.9k 0.8× 176 12.5k
Michel Marre 8.7k 1.0× 3.8k 1.1× 2.3k 0.7× 3.3k 1.2× 2.3k 1.0× 423 17.2k
Andrzej S. Królewski 5.8k 0.6× 2.5k 0.7× 5.3k 1.7× 3.2k 1.1× 2.2k 1.0× 190 15.7k
Janet B. McGill 9.1k 1.0× 3.0k 0.9× 2.2k 0.7× 3.4k 1.2× 1.6k 0.7× 236 16.2k
Mark E. Molitch 13.4k 1.5× 2.1k 0.6× 3.0k 1.0× 5.6k 2.0× 1.4k 0.6× 326 20.0k
Knut Borch‐Johnsen 4.6k 0.5× 3.1k 0.9× 1.6k 0.5× 1.6k 0.6× 2.1k 0.9× 206 12.3k
Carol Forsblom 5.2k 0.6× 2.2k 0.6× 2.3k 0.8× 2.5k 0.9× 1.7k 0.7× 276 12.2k
Sophia Zoungas 7.2k 0.8× 3.6k 1.0× 2.6k 0.8× 2.6k 0.9× 1.2k 0.5× 290 14.8k
Per‐Henrik Groop 9.8k 1.1× 3.7k 1.1× 3.5k 1.1× 4.3k 1.5× 4.2k 1.8× 522 23.0k

Countries citing papers authored by H. Keen

Since Specialization
Citations

This map shows the geographic impact of H. Keen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Keen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Keen more than expected).

Fields of papers citing papers by H. Keen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Keen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Keen. The network helps show where H. Keen may publish in the future.

Co-authorship network of co-authors of H. Keen

This figure shows the co-authorship network connecting the top 25 collaborators of H. Keen. A scholar is included among the top collaborators of H. Keen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Keen. H. Keen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keen, H.. (2001). The WHO multinational study of vascular disease in diabetes. Diabetologia. 44(S2). S1–S2. 59 indexed citations
2.
Pierce, M., Daniel Harding, Deborah Ridout, H. Keen, & Clare Bradley. (2001). Risk and prevention of type II diabetes: offspring's views.. PubMed Central. 51(464). 194–9. 35 indexed citations
3.
Keen, H., Paul R. Fisher, & Paul Draper. (1997). NHS bonds could be alternative to private finance initiative for NHS. BMJ. 315(7122). 1620.1–1620.1. 3 indexed citations
4.
Viberti, Gian Carlo, S. M. Marshall, Robin N. Beech, et al.. (1996). Report on renal disease in diabetes.. PubMed. 13(9 Suppl 4). S6–12. 16 indexed citations
5.
Keen, H.. (1996). Saint Vincent and improving diabetes care. Specialist U.K Workgroup Reports. Introduction.. PubMed. 13(9 Suppl 4). S3–5. 2 indexed citations
6.
Jones, S. L., et al.. (1989). Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria.. BMJ. 298(6672). 487–490. 173 indexed citations
7.
Bending, J J, J. C. Pickup, G C Viberti, & H. Keen. (1984). Glycaemic control in diabetic nephropathy.. BMJ. 288(6425). 1187–1191. 6 indexed citations
8.
Keen, H., R. J. Jarrett, C. R. Strakosch, et al.. (1983). Epidemiological study of prevalence of chlorpropamide alcohol flushing in insulin dependent diabetics, non-insulin dependent diabetics, and non-diabetics.. BMJ. 287(6404). 1509–1512. 10 indexed citations
9.
Bell, James, James S. Wainscoat, Julie M. Old, et al.. (1983). Maturity onset diabetes of the young is not linked to the insulin gene.. BMJ. 286(6365). 590–592. 20 indexed citations
10.
Fuller, J. H., M Shipley, G Rose, R. J. Jarrett, & H. Keen. (1983). Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.. BMJ. 287(6396). 867–870. 510 indexed citations breakdown →
11.
Viberti, Giancarlo, R. W. Bilous, David Mackintosh, J J Bending, & H. Keen. (1983). Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. BMJ. 286(6365). 598–602. 188 indexed citations
12.
Knight, Graham, et al.. (1982). BIOSYNTHETIC HUMAN INSULIN IN THE TREATMENT OF DIABETES. The Lancet. 320(8294). 354–357. 61 indexed citations
13.
Williams, Geoffrey M., et al.. (1982). Greatly accelerated removal of circulating insulin a new mechanism for massive insulin resistance. Diabetologia. 23(5). 476. 1 indexed citations
14.
Fuller, J. H., H. Keen, R. J. Jarrett, et al.. (1979). Haemostatic variables associated with diabetes and its complications.. BMJ. 2(6196). 964–966. 234 indexed citations
15.
Crome, P & H. Keen. (1978). Partial lipodystrophy and insulin-resistant diabetes.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(2). 81–4. 8 indexed citations
16.
Keen, H.. (1975). Immunity and Autoimmunity in Diabetes Mellitus.. Journal of the Royal Society of Medicine. 68(5). 334–334. 26 indexed citations
17.
Jarrett, R. J., et al.. (1972). Diurnal Variation in Oral Glucose Tolerance: Blood Sugar and Plasma Insulin Levels Morning, Afternoon, and Evening. BMJ. 1(5794). 199–201. 130 indexed citations
18.
Jarrett, R. J. & H. Keen. (1969). Diurnal Variation of Oral Glucose Tolerance: a Possible Pointer to the Evolution of Diabetes Mellitus. BMJ. 2(5653). 341–344. 102 indexed citations
20.
Boyns, D. R., R. J. Jarrett, & H. Keen. (1967). Intestinal hormones and plasma insulin: an insulinotropic action of secretin.. BMJ. 2(5553). 676–678. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026